These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2293223)

  • 1. Effects of a diluent on the retarded-release property of acrylate methacrylate--salicylic acid coacervates.
    Okor RS; Yahaya MA
    Pharm Res; 1990 Nov; 7(11):1208-9. PubMed ID: 2293223
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
    Villanova JC; Ayres E; Oréfice RL
    Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A; Kolter K; Bodmeier R
    Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
    Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
    Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical acrylic beads obtained by suspension polymerization containing cellulose nanowhiskers as excipient for drug delivery.
    Villanova JC; Ayres E; Carvalho SM; Patrício PS; Pereira FV; Oréfice RL
    Eur J Pharm Sci; 2011 Mar; 42(4):406-15. PubMed ID: 21241802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
    Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural polymers, gums and mucilages as excipients in drug delivery.
    Kumar S; Gupta SK
    Polim Med; 2012; 42(3-4):191-7. PubMed ID: 23457960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
    Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
    Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
    Billa N; Yuen KH; Peh KK
    Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
    Kumar P; Singh I
    Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M; Aguilar-de-Leyva Á; Caraballo I
    Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
    Zelkó R; Orbán A; Süvegh K
    J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of starch-based excipients used in extended-release tablets: a review.
    Hong Y; Liu G; Gu Z
    Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets.
    Amador Ríos Z; Ghaly ES
    Biomed Res Int; 2015; 2015():423615. PubMed ID: 26185757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.